Elahere 100 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJG5J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,438
Award facts
- Contract value 100% obligated
- $37,438.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 6, 2026, the Defense Logistics Agency awarded a delivery order valued at $37,438.48 to AmerisourceBergen Drug Corp for the supply of Elahere (mirvetuximab soravtansine) 100 mg/20 mL vials. This firm fixed-price, non-set-aside contract is scheduled for completion by January 28, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical extending through December 2031. This prime IDC vehicle enables comprehensive pharmaceutical and medical supply support for military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company competes on a full and open basis for federal contracts, demonstrating its capability to meet stringent government procurement requirements. The delivery of Elahere, an FDA-approved oncology therapeutic, reflects the company's role in supplying specialized pharmaceutical products to support the Defense Health Agency and other federal healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FJG5J?
SPE2DR26FJG5J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FJG5J worth?
The government has obligated $37,438 on SPE2DR26FJG5J.
Is contract SPE2DR26FJG5J an order under another contract?
Yes. SPE2DR26FJG5J is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJG5J competed?
The extent of competition for SPE2DR26FJG5J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award